The Receptor SIGIRR Suppresses Th17 Cell Proliferation via Inhibition of the Interleukin-1 Receptor Pathway and mTOR Kinase Activation
Open Access
- 7 January 2010
- Vol. 32 (1), 54-66
- https://doi.org/10.1016/j.immuni.2009.12.003
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- The mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage CommitmentImmunity, 2009
- IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiationProceedings of the National Academy of Sciences, 2009
- Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 SignalingImmunity, 2009
- An overview of IL-17 function and signalingCytokine, 2008
- Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigensThe Journal of Experimental Medicine, 2008
- IL-12– and IL-23–modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibitionThe Journal of Experimental Medicine, 2008
- T Helper 17 Lineage Differentiation Is Programmed by Orphan Nuclear Receptors RORα and RORγImmunity, 2008
- IL-21 Is Produced by Th17 Cells and Drives IL-17 Production in a STAT3-dependent MannerJournal of Biological Chemistry, 2007
- A crucial role for interleukin (IL)-1 in the induction of IL-17–producing T cells that mediate autoimmune encephalomyelitisThe Journal of Experimental Medicine, 2006
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006